Metabolite ratios to assumed stable creatine level may confound the quantification of proton brain MR spectroscopy

Magnetic Resonance Imaging

Volumn 21, Issue 8, 2003, Pages 923-928

  Li, Belinda S Y ^a   Wang, Hao ^b   Gonen, Oded ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; CREATINE; N ACETYLASPARTIC ACID;

ADULT; ARTICLE; BRAIN REGION; COVARIANCE; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MATHEMATICAL ANALYSIS; METABOLITE; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

EID: 0242580198     PISSN: 0730725X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0730-725X(03)00181-4     Document Type: Article

References (27)

1. Tartaglia MC, Narayanan S, De Stefano N, Arnaoutelis R, Antel SB, Francis SJ, Santos AC, Lapierre Y, Arnold DL. Choline is increased in pre-lesional normal appearing white matter in multiple sclerosis. J Neurol 2002;249:1382-90.
2. De Stefano N, Narayanan S, Francis SJ, Smith S, Mortilla M, Tartaglia MC, Bartolozzi ML, Guidi L, Federico A, Arnold DL. Diffuse axonal and tissue injury in patients with multiple sclerosis with low cerebral lesion load and no disability. Arch Neurol 2002;59:1565-71.
3. Arnold DL, De Stefano N, Narayanan S, Matthews PM. Proton MR spectroscopy in multiple sclerosis. Neuroimaging Clin N Am 2000;10:789-98 ix-x.
4. De Stefano N, Narayanan S, Francis GS, Arnaoutelis R, Tartaglia MC, Antel JP, Matthews PM, Arnold DL. Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability. Arch Neurol 2001;58:65-70.
5. [51 Bertolino A, Callicott JH, Nawroz S, Mattay VS, Duyn JH, Tedeschi G, Frank JA, Weinberger DR. Reproducibility of proton magnetic resonance spectroscopic imaging in patients with schizophrenia. Neuropsychopharmacology 1998;18:1-9.
6. Winsberg ME, Sachs N, Tate DL, Adalsteinsson E, Spielman D, Ketter TA. Decreased dorsolateral prefrontal N-acetyl aspartate in bipolar disorder. Biol Psychiatry 2000;47:475-81.
7. Capizzano AA, Schuff N, Amend DL, Tanabe JL, Norman D, Maudsley AA, Jagust W, Chui HC, Fein G, Segal MR, Weiner MW. Subcortical ischemic vascular dementia: assessment with quantitative MR imaging and 1H MR spectroscopy. AJNR Am J Neuroradiol 2000;21:621-30.
8. Cecil KM, Hills EC, Sandel ME, Smith DH, McIntosh TK, Mannon LJ, Sinson GP, Bagley LJ, Grossman RI, Lenkinski RE. Proton magnetic resonance spectroscopy for detection of axonal injury in the splenium of the corpus callosum of brain-injured patients. J Neurosurg 1998;88:795-801.
9. Vermathen P, Laxer KD, Matson GB, Weiner MW. Hippocampal structures: anteroposterior N-acetylaspartate differences in patients with epilepsy and control subjects as shown with proton MR spectroscopic imaging. Radiology 2000;214:403-10.
10. Li BS, Babb JS, Soher BJ, Maudsley AA, Gonen O. Reproducibility of 3D proton spectroscopy in the human brain. Magn Reson Med 2002;47:439-46.
11. Lyons L. A practical guide to data analysis for physical science students. Cambridge: Cambrige University Press, 1991, 1-pp. 25.
12. Gonen O, Murdoch JB, Stoyanova R, Goelman G. 3D multivoxel proton spectroscopy of human brain using a hybrid of 8th-order Hadamard encoding with 2D chemical shift imaging. Magn Reson Med 1998;39:34-40.
13. Kreis R, Ernst T, Ross BD. Absolute concentrations of water and metabolites in the human brain. II. Metabolite concentrations. J Magn Reson 1993;102:9-19.
14. Gonen O, Mohebbi A, Stoyanova R, Brown TR. In vivo phosphorus polarization transfer and decoupling from protons in three-dimensional localized nuclear magnetic resonance spectroscopy of human brain. Magn Reson Med 1997;37:301-6.
15. Marion D, Ikura M, Bax A. Improved solvent suppression in one- and two-dimensional NMR spectra by convolution of time domain data. J Magn Reson 1989;84:425-30.
16. 31P metabolite images. Radiology 1990;177:643-9.
17. Soher BJ, Young K, Govindaraju V, Maudsley AA. Automated spectral analysis III: Application to in vivo proton MR spectroscopy and spectroscopic imaging. Magn Reson Med 1998;40:822-31.
18. Soher BJ, Young K, Maudsley AA. Representation of strong baseline contributions in 1HMR spectra. Magn Reson Med 2001;45:966-72.
19. Soher BJ, van Zijl PC, Duyn JH, Barker PB. Quantitative proton MR spectroscopic imaging of the human brain. Magn Reson Med 1996;35:356-63.
20. Christiansen P, Toft P, Larsson HB, Stubgaard M, Henriksen O. The concentration of N-acetyl aspartate, creatine + phosphocreatine, and choline in different parts of the brain in adulthood and senium. Magn Reson Imaging 1993;11:799-806.
21. Li S, Dardzinski BJ, Collins CM, Yang QX, Smith MB. Three-dimensional mapping of the static field inside the human head. Magn Reson Med 1996;36:705-14.
22. Pan JW, Twieg DB, Hetherington HP. Quantitative spectroscopic imaging of the human brain. Magn Reson Med 1998;40:363-9.
23. Bottomley PA. The trouble with spectroscopy papers. J Magn Reson Imag 1992;2:1-8.
24. Davies SE, Newcombe J, Williams SR, McDonald WI, Clark JB. High resolution proton NMR spectroscopy of multiple sclerosis lesions. J Neurochem 1995;64:742-8.
25. 1H spectroscopy imaging at 4.1 T. Magn Reson Med 1996;36:72-7.
26. Suhy J, Rooney WD, Goodkin DE, Capizzano AA, Soher BJ, Maudsley AA, Waubant E, Andersson PB, Weiner MW. H-1 MRSI comparison of white matter and lesions in primary progressive and relapsing-remitting MS. Multiple Sclerosis 2000;6:148-55.
27. Weber-Fahr W, Ende G, Braus DF, Bachert P, Soher BJ, Henn FA, Buchel C. A fully automated method for tissue segmentation and CSF-correction of proton MRSI metabolites corroborates abnormal hippocampal NAA in schizophrenia. Neuroimage 2002;16:49-60.